Urologix Financial Statements From 2010 to 2024
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Check Urologix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Urologix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Urologix financial statements analysis is a perfect complement when working with Urologix Valuation or Volatility modules.
Urologix |
Urologix Company Return On Asset Analysis
Urologix's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Urologix Return On Asset | -0.0762 |
Most of Urologix's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Urologix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Urologix has a Return On Asset of -0.0762. This is 99.13% lower than that of the Health Care Equipment & Supplies sector and 99.58% lower than that of the Health Care industry. The return on asset for all United States stocks is 45.57% lower than that of the firm.
Urologix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Urologix's current stock value. Our valuation model uses many indicators to compare Urologix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Urologix competition to find correlations between indicators driving Urologix's intrinsic value. More Info.Urologix is rated second in return on asset category among its peers. It is rated second in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Urologix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Urologix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Urologix Financial Statements
Urologix investors use historical fundamental indicators, such as Urologix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Urologix. Please read more on our technical analysis and fundamental analysis pages.
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia in the United States. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota. UROLOGIX operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 61 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |